Improving decision-making for rheumatoid arthritis patients with cancer regarding treatment options
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
This study is looking to help patients with rheumatoid arthritis who also have cancer by understanding their thoughts and experiences with certain medications, so that doctors and patients can make better treatment choices together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10898084 on NIH RePORTER |
What this research studies
This research focuses on enhancing the decision-making process for patients with rheumatoid arthritis (RA) who also have cancer. It aims to understand the experiences and perspectives of these patients regarding the use of disease-modifying anti-rheumatic drugs (DMARDs), which are often avoided due to concerns about their safety in the context of cancer. By employing a mixed methods approach, the research will gather qualitative and quantitative data to inform treatment guidelines and support shared decision-making between patients and healthcare providers. The goal is to ensure that patients' values and preferences are considered when making treatment choices.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with rheumatoid arthritis who are also currently undergoing treatment for cancer.
Not a fit: Patients with rheumatoid arthritis who do not have a concurrent cancer diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with rheumatoid arthritis and cancer.
How similar studies have performed: Previous studies have shown that shared decision-making approaches can improve patient satisfaction and treatment adherence, suggesting potential success for this research.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Singh, Namrata — University of Washington
- Study coordinator: Singh, Namrata
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.